Estee Lauder invests in luxury skincare brand 111SKIN

13 articles · Updated · MarketWatch · Apr 29

Estee Lauder has taken a minority stake in 111SKIN, founded by surgeon Yannis Alexandrides, who remains at the helm with his management team.
The investment aims to expand 111SKIN's global reach while maintaining its clinical, treatment-inspired approach, reflecting Estee Lauder's confidence in the growing skincare market.
Estee Lauder emphasizes consumer demand for visible results and innovation in skincare, aligning the move with its 'Beauty Reimagined' vision; financial terms of the deal were not disclosed.

How will this deal reshape the battle for the booming $178 billion global skincare market?

After divesting major brands, why did Estee Lauder choose a minority stake in a niche clinical label?

Is 'skin longevity' a true scientific breakthrough or just clever marketing for existing anti-aging formulas?

With a $50M brand now backed by Estee Lauder, what is the science behind its core NAC Y²™ technology?

Can a surgeon-founded luxury brand maintain its clinical prestige on mass platforms like TikTok Shop?